Students should:
1. Understand the techniques used to measure medicinal drug consumption;
2. Understand the factors that influence the prescribing and consumption of medicinal drugs;
3. Understand the methods used to measure beneficial and adverse effects of drugs in the community;
4. Be able to correctly interpret data on drug consumption and effects;
5. Understand the techniques used in measuring the cost-effectiveness of drugs; and
6. Be able to correctly interpret pharmacoeconomic data and understand how cost- effectiveness data can be used to set drug prices and control drug budgets.

1. Drug utilisation studies, international measures of drug consumption;
2. International comparisons of drug consumption, the impact of socio-economic factors and pharmaceutical industry actions on prescribing and consumption of medicinal drugs;
3. Measuring efficacy of drugs by randomized and non-randomised studies, biostatistical measures of drug use and effects;
4. Logic of cohort and case-control studies of adverse effects, voluntary adverse reaction reports and their interpretation, measuring the costs and outcomes of community drug use;
5. Cost-minimisation, cost-effectiveness and cost-utility analysis, evidence-based medicine and pharmacoeconomic analysis, using pharmacoeconomic analyses to make formulary decisions and set prices; and
6. Reference pricing, evidence-based procurement techniques in drug program management.

Replaces PHAR6010 Epidemiology and Pharmacoeconomics 10 Units

N/A

0

PHAR6006 OR PHAR6133 Pharmacotherapeutics 1

Internal Mode

Problem Based Learning
Lecture
Self Directed Learning
Tutorial

Lecture: for 2 hour(s) per Week for 10 weeks
Tutorial: for 2 hour(s) per Week for 10 weeks